Evidence map›Paper›PMID 19887394›Full record

ArticleThe Journal of experimental medicine2009

Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.

Bu Yin, Velibor Savic, Marisa M Juntilla, Andrea L Bredemeyer, Katherine S Yang-Iott, Beth A Helmink, Gary A Koretzky, Barry P Sleckman, Craig H Bassing

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. FLASH-RT does not affect chromosome translocations and junction structures beyond that of CONV-RT dose-rates.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  4. Article
  5. DNA Damage Response and Repair in Adaptive Immunity.Frontiers in cell and developmental biology · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genome Instability and γH2AX.International journal of molecular sciences · 2017
    Review
  13. Immature Lymphocytes InhibitJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  14. Contribution of canonical nonhomologous end joining to chromosomal rearrangements is enhanced by ATM kinase deficiency.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Histone deacetylation critically determines T cell subset radiosensitivity.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Bu YinCell and Molecular Biology Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Velibor Savic
Marisa M Juntilla
Andrea L Bredemeyer
Katherine S Yang-Iott
Beth A Helmink
Gary A Koretzky
Barry P Sleckman
Craig H Bassing
University of Pennsylvania · USWashington University in St. Louis · USChildren's Hospital of Philadelphia · USCancer Research Institute of the Slovak Academy of Sciences · SK

Funding

ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
Molecular Pathways in Suppression and Development of T Lineage LymphomasR01CA125195 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2007 to 2011
$1.6M
NCI NIH HHS R01 CA 125195NCI NIH HHS R01 CA125195NIAID NIH HHS R01 AI074953
6 · The paper itself

Abstract

The H2AX core histone variant is phosphorylated in chromatin around DNA double strand breaks (DSBs) and functions through unknown mechanisms to suppress antigen receptor locus translocations during V(D)J recombination. Formation of chromosomal coding joins and suppression of translocations involves the ataxia telangiectasia mutated and DNA-dependent protein kinase catalytic subunit serine/threonine kinases, each of which phosphorylates H2AX along cleaved antigen receptor loci. Using Abelson transformed pre-B cell lines, we find that H2AX is not required for coding join formation within chromosomal V(D)J recombination substrates. Yet we show that H2AX is phosphorylated along cleaved Igkappa DNA strands and prevents their separation in G1 phase cells and their progression into chromosome breaks and translocations after cellular proliferation. We also show that H2AX prevents chromosome breaks emanating from unrepaired RAG endonuclease-generated TCR-alpha/delta locus coding ends in primary thymocytes. Our data indicate that histone H2AX suppresses translocations during V(D)J recombination by creating chromatin modifications that stabilize disrupted antigen receptor locus DNA strands to prevent their irreversible dissociation. We propose that such H2AX-dependent mechanisms could function at additional chromosomal locations to facilitate the joining of DNA ends generated by other types of DSBs.

Indexed as

Chromosome BreakageDNA Breaks, Double-StrandedAnimalsAtaxia Telangiectasia Mutated ProteinsB-LymphocytesCell Cycle ProteinsCell Line, TransformedChromatinG1 PhaseHistonesMiceMice, KnockoutPhosphorylationProtein Serine-Threonine KinasesQuantitative Trait LociReceptors, Antigen, B-CellAtaxia Telangiectasia Mutated ProteinsAtr protein, mouseCell Cycle ProteinsChromatingamma-H2AX protein, mouseHistonesProtein Serine-Threonine KinasesReceptors, Antigen, B-CellReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID19887394
PMCPMC2806628
OpenAlexW2096033448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.